Abstract
Objectives The uptake and actual use of the current guidelines from the American College of Obstetrics and Gynecology (ACOG) is unknown. Methods Family planning providers across Colorado and Iowa were surveyed as part of statewide initiatives to reduce unintended pregnancy in 2010 and 2012, both before and after the release of the guidelines. These initiatives focused on the promotion of intrauterine devices (IUDs) and implants. These surveys included questions on providers’ views regarding the suitability and safety of the copper T IUD, hormonal IUD, and single rod implant for various subgroups of clients. The results are contrasted with guidelines provided in July of 2011 by ACOG. This strategy provides both baseline and follow-up models about the methods promoted in these guidelines. Results Findings show that there is some improvement in beliefs that IUDs are suitable and safe for women who are post-partum, post-abortion, have had an ectopic pregnancy, are nulliparous, teenagers, or have a history of STIs. However, these clinicians’ views are not entirely in alignment with ACOG recommendations in their beliefs that these methods should not be used immediately post-partum or post-abortion. Notable percentages of these clinicians were hesitant to recommend these effective methods for other groups of patients, approved for use by ACOG. Conclusions While the cost of these methods is a barrier to adoption, these data suggest that there are continuing provider barriers to their use as well. The paper concludes with suggestions for further training for family planning providers.
Similar content being viewed by others
References
American College of Obstetricians and Gynecologists (ACOG) (2009). Increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy. Committee Opinion, 450(114), 1434–1438.
American College of Obstetricians and Gynecologists (ACOG) (2011). Long-acting reversible contraception: Implants and intrauterine devices. Practice Bulletin, 121, 1–13.
American College of Obstetricians and Gynecologists (ACOG) (2012). Adolescents and long-acting reversible contraception: Implants and intrauterine devices. Committee Opinion, 539, 1–7.
Bhathena, R. K., & Guillebaud, J. (2008). Intrauterine contraception: An update. Journal of Obstetrics and Gynecology, 28(3), 262–265.
Biggs, M. A., Harper, C. C., Malvin, J., & Brindis, C. D. (2014). Factors influencing the provision of long-acting reversible contraception in California. Obstetrics & Gynecology, 123, 593–602.
Brito, M. B., Ferriani, R. A., Meijers, J. C., Garcia, A. A., Quintana, S. M., Silva de Sà, M. F., & Vieira, C. S. (2012). Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: A randomized controlled trial. Thrombosis Research, 130(3), 355–360.
Cheng, D. (2000). The intrauterine device: Still misunderstood after all these years. Southern Medical Journal, 93(9), 859–864.
Deans, E. I., & Grimes, D. A. (2009). Intrauterine devices for adolescents: A systematic review. Contraception, 79, 418–423.
Diaz, V. A., Hughes, N., Dickerson, L. M., Wessell, A. M., & Carek, P. J. (2001). Clinician knowledge about use of intrauterine devices in adolescents in South Carolina AHEC. Family Medicine, 43(6), 407–411.
Doyle, J., Stern, L., Hagan, M., Hao, J., & Gricar, J. (2008). Advances in contraception: IUDs from a managed care perspective. Journal of Women’s Health, 17(6), 987–992.
Finer, L. B., Jerman, J., & Kavanaugh, M. L. (2012). Changes in use of long-acting contraceptive methods in the US, 2007–2009. Fertility and Sterility, 98(4), 893–897.
Guttmacher Institute (2012). Facts on unintended pregnancy in the US. In brief: fact sheet. http://www.guttmacher.org/pubs.6.
Harper C. C., Stratton L., Raine T. R., Thompson K., Henderson J. T., Blum M., ... Speidel J. J. (2013). Counseling and provision of long-acting reversible contraception in the US: National survey of nurse practitioners. Preventive Medicine, 57, 883–888
Harper, C. C., Blum, M., De Bocanegra, H. T., Darney, P. D., Speidel, J. J., Policar, M., & Drey, E. A. (2008). Challenges in translating evidence to practice: The provision of intrauterine contraception. Obstetrics and Gynecology, 111(6), 1359–1369.
Harper, C. C., Henderson, J., Raine, T., Goodman, S., Darney, P., Thompson, K., ... Speidel, J. (2012). Evidence-based IUD practice: Family physicians and obstetrician-gynecologists. Family Medicine, 44(9), 637–645.
Harper, C. C., Stratton, L., Raine, T. R., Thompson, K., Henderson, J. T., ... Speidel, J. J. (2013). Counseling and provision of long-acting reversible contraception in the US: National survey of nurse practitioners. Preventive Medicine, 57, 883–888.
Hubacher, D. (2002). The checkered history and bright future of intrauterine contraception in the United States. Perspectives on Sexual and Reproductive Health, 34(2), 98–103.
Institute of Medicine (2011). Clinical preventive services for women. http://www.iom.edu/Reports/2011/Clinical-Preventive-Services-for-Women-Closing-the-Gaps.aspx.
Kane, R., Irving, G., Brown, S., Parkes, N., Walling, M., & Killick, S. (2009). Long-acting, reversible and permanent methods of contraception: Insight into women’s choice of method. Quality in Primary Care, 17, 107–114.
Lewis, C., Darney, P., & Thiel de Bocanegra, H. (2013). Intrauterine contraception: Impact of provider training on participant knowledge and provision. Contraception, 88, 226–231.
Luchowski, A. T., Anderson, B. L., Power, M. L., Raglan, G. B., Espey, E., & Schulkin, J. (2014). Obstetrician-gynecologists and contraception: Practice and opinions about the use of IUDs in nulliparous women, adolescents and other patient populations. Contraception, 86, 572–577.
National Campaign to Prevent Teen and Unplanned Pregnancy (2012). Unplanned pregnancy among unmarried young women. Briefly, pp 1–4. Washington, DC: The National Compaign
Peipert JF, Madden T, Allsworth J, Secura G (2012). Preventing unintended pregnancies by providing no-cost contraception. Obstetrics and Gynecology, 120, 1291.
Postlethwaite, D., Shaber, R., Mancuso, V., Flores, J., & Armstrong, M. A. (2007). Intrauterine contraception: Evaluation of clinician practice patterns in Kaiser Permanente Northern California. Contraception, 75, 177–184.
Speidel, J. J., Harper, C. C., & Shields, W. C. (2008). The potential of long-acting reversible contraception to decrease unintended pregnancy. Contraception, 78, 197–200.
Stanwood, N. L., Garrett, J. M., & Konrad, T. R. (2002). Obstetrician-gynecologists and the intrauterine device: A survey of attitudes and practices. Obstetrics and Gynecology, 99, 275–280.
Stoddard, A., McNicholas, C., & Peipert, J. F. (2011). Efficacy and safety of long-acting reversible contraception. Drugs, 71(8), 969–980.
Tocce, K. M., Sheeder, J., & Teal, S. (2012). Rapid repeat pregnancy in adolescents: Do immediate postpartum contraceptive implants make a difference? American Journal of Obstetrics and Gynecology, 206, 481–483.
Trussel, J., Lalla, A. M., Doan, Q. V., Reyes, E., Pinto, L., & Gricar, J. (2009). Cost effectiveness of contraceptives in the United States. Contraception, 79(1), 5–14.
Tyler, C. P., Whiteman, M. K., Zapata, L. B., Curtis, K. M., Hillis, S. D., & Marchbanks, P. A. (2012). Health care provider attitudes and practices related to intrauterine devices for nulliparous women. Obstetrics and Gynecology, 119, 762–771.
United Nations Department of Economic and Social Information and Policy Analysis (2011). World contraceptive use 2011. New York: United Nations Publications.
Venkat, P., Masch, R., Ng, E., Cremer, M., Richman, S., & Arsian, A. (2008). Knowledge and beliefs about contraception in urban Latina women. Journal of Community Health, 22, 357–362.
Acknowledgements
The initiatives in Iowa and Colorado, and their evaluations, were funded by an anonymous foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Philliber, A.E., Hirsch, H., Brindis, C.D. et al. The Use of ACOG Guidelines: Perceived Contraindications to IUD and Implant Use Among Family Planning Providers. Matern Child Health J 21, 1706–1712 (2017). https://doi.org/10.1007/s10995-017-2320-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10995-017-2320-1